NCT00897533 2017-05-19
Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer
Eastern Cooperative Oncology Group
Completed
Eastern Cooperative Oncology Group
SWOG Cancer Research Network